Stay updated on Roxadustat Clinical Trial for Anemia in ESRD on Dialysis
Sign up to get notified when there's something new on the Roxadustat Clinical Trial for Anemia in ESRD on Dialysis page.

Latest updates to the Roxadustat Clinical Trial for Anemia in ESRD on Dialysis page
- Check5 days agoChange DetectedThe record describes a completed Phase 3 study comparing roxadustat with epoetin alfa for anemia in people newly starting dialysis for end-stage renal disease. It also presents participant criteria, study locations and outcomes, results-related publications, and study documents.SummaryDifference100%

- Check12 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check19 days agoChange DetectedA notice was added announcing NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and linking to related updates and FAQs.SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision indicator changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the study record page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header and a Home link, indicating the study record is temporarily inaccessible. The detailed study content that previously appeared on the page has been removed or hidden.SummaryDifference18%

Stay in the know with updates to Roxadustat Clinical Trial for Anemia in ESRD on Dialysis
Enter your email address, and we'll notify you when there's something new on the Roxadustat Clinical Trial for Anemia in ESRD on Dialysis page.